Money is no object when you've got a very promising drug or an approved IND. Partnering with an established drug company can be done with zero dilution to stockholders.
Ann: US FDA Grants Qualified Infectious Disease Product Designati, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 41.5¢ | $41.64K | 97.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33114 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 3726 | 1 |
View Market Depth
| Last trade - 12.08pm 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |